Evidence map›Paper›PMID 37586368›Full record

ArticleDevelopmental cell2023

RNA polymerase II pausing temporally coordinates cell cycle progression and erythroid differentiation.

Danya J Martell, Hope E Merens, Alexis Caulier, Claudia Fiorini, Jacob C Ulirsch, Robert Ietswaart, Karine Choquet, Giovanna Graziadei, Valentina Brancaleoni, Maria Domenica Cappellini and 8 more

Open access · greenAbstract read
In one paragraph

Article in Developmental cell, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. CRL3Molecular cell · 2024
    Article
  15. Article
  16. Review
  17. Loss-of-Function Variants inInternational journal of molecular sciences · 2024
    Review
  18. Article
  19. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

Danya J MartellDepartment of Genetics, Harvard University, Boston, MA, USA; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Hope E MerensDepartment of Genetics, Harvard University, Boston, MA, USA.
Alexis CaulierDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Claudia FioriniDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Jacob C UlirschDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Robert IetswaartDepartment of Genetics, Harvard University, Boston, MA, USA.
Karine ChoquetDepartment of Genetics, Harvard University, Boston, MA, USA.
Giovanna GraziadeiDepartment of Clinical Sciences and Community, University of Milan, IRCCS Ca'Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.
Valentina BrancaleoniDepartment of Clinical Sciences and Community, University of Milan, IRCCS Ca'Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.
Maria Domenica CappelliniDepartment of Clinical Sciences and Community, University of Milan, IRCCS Ca'Granda Foundation Maggiore Policlinico Hospital, Milan, Italy.
Caroline ScottMRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Nigel RobertsMRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Melanie ProvenOxford Genetics Laboratories, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Noémi B A RoyMRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK; NIHR Oxford Biomedical Research Centre and BRC/NHS Translational Molecular Diagnostics Centre, John Radcliffe Hospital, Oxford, UK; Department of Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Christian BabbsMRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Douglas R HiggsMRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Vijay G SankaranDivision of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Electronic address: sankaran@broadinstitute.org.
L Stirling ChurchmanDepartment of Genetics, Harvard University, Boston, MA, USA. Electronic address: churchman@genetics.med.harvard.edu.
Broad Institute · USHarvard University · USUniversity of Oxford · GBUniversity of Milan · ITJohn Radcliffe Hospital · GBOxford University Hospitals NHS Trust · GB

Funding

TRAINING GRANT IN GENETICST32GM007748 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Anne O'Donnell-Luria, Louise Wilkins-Haug · 1985 to 2026
$12.0M
Mechanisms of Transcriptional Control Revealed by Nascent Transcript SequencingR01HG007173 · NHGRI · HARVARD MEDICAL SCHOOL · PI Lee Stirling Churchman · 2013 to 2026
$6.7M
Systematic Genetic Dissection of Human ErythropoiesisR01DK103794 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI Vijay Ganesh Sankaran · 2014 to 2026
$5.9M
Next generation functional genomics of hematology traitsR01HL146500 · NHLBI · UNIVERSITY OF WASHINGTON · PI ALEXANDER P REINER · 2020 to 2026
$5.7M
Discovering the regulatory roles of transcription during erythropoiesis, one nucleotide at a timeF32GM125238 · NIGMS · HARVARD MEDICAL SCHOOL · PI SMART, DANYA J · 2017 to 2019
$184k
Medical Research Council MR/T014067/1Medical Research Council MR/X001210/1NHGRI NIH HHS R01 HG007173NHLBI NIH HHS R01 HL146500NIDDK NIH HHS R01 DK103794NIGMS NIH HHS F32 GM125238NIGMS NIH HHS T32 GM007748
6 · The paper itself

Abstract

Controlled release of promoter-proximal paused RNA polymerase II (RNA Pol II) is crucial for gene regulation. However, studying RNA Pol II pausing is challenging, as pause-release factors are almost all essential. In this study, we identified heterozygous loss-of-function mutations in SUPT5H, which encodes SPT5, in individuals with β-thalassemia. During erythropoiesis in healthy human cells, cell cycle genes were highly paused as cells transition from progenitors to precursors. When the pathogenic mutations were recapitulated by SUPT5H editing, RNA Pol II pause release was globally disrupted, and as cells began transitioning from progenitors to precursors, differentiation was delayed, accompanied by a transient lag in erythroid-specific gene expression and cell cycle kinetics. Despite this delay, cells terminally differentiate, and cell cycle phase distributions normalize. Therefore, hindering pause release perturbs proliferation and differentiation dynamics at a key transition during erythropoiesis, identifying a role for RNA Pol II pausing in temporally coordinating the cell cycle and erythroid differentiation.

Indexed as

Gene Expression RegulationRNA Polymerase IICell CycleCell DifferentiationHumansNuclear ProteinsTranscriptional Elongation FactorsTranscription, GeneticNuclear ProteinsRNA Polymerase IISUPT5H protein, humanTranscriptional Elongation Factorscell cycledifferentiationerythropoiesishemoglobinhuman genetic variationRNA Pol II pausingSPT5SUPT5Htranscriptional regulation

Identifiers

PMID37586368
PMCPMC10615711
OpenAlexW4385841552

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.